These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1832602)

  • 1. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
    Keller N; Sykulski R; Larsen J
    Clin Physiol; 1991 May; 11(3):199-210. PubMed ID: 1832602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
    Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
    Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure.
    Münzel T; Drexler H; Holtz J; Kurtz S; Just H
    Circulation; 1991 Jan; 83(1):191-201. PubMed ID: 1845857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of intravenous atrial natriuretic factor with furosemide in patients with heart failure.
    Connelly TP; Francis GS; Williams KJ; Beltran AM; Cohn JN
    Am Heart J; 1994 Feb; 127(2):392-9. PubMed ID: 8296708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose infusion of atrial natriuretic factor in mild essential hypertension.
    Tonolo G; Richards AM; Manunta P; Troffa C; Pazzola A; Madeddu P; Towrie A; Fraser R; Glorioso N
    Circulation; 1989 Oct; 80(4):893-902. PubMed ID: 2529059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function.
    Dubois-Rande JL; Adnot S; Benvenuti C; Merlet P; Hittinger L; Sediame S; Chabrier E; Braquet P; Castaigne A
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):608-14. PubMed ID: 1711628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic factor during exercise in patients with congestive heart failure.
    Keller N; Larsen J; Sykulski R; Storm T; Thamsborg G
    Acta Endocrinol (Copenh); 1988 Jun; 118(2):168-72. PubMed ID: 2968748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A; Stanek B; Kubecova L; Vitovec J; Spinar J; Yilmaz N; Kos T; Hartter E; Frey B; Pacher R
    Jpn Heart J; 1999 May; 40(3):321-34. PubMed ID: 10506854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
    Chien YW; Trippodo NC; Frohlich ED
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.
    Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA
    Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac secretion of atrial natriuretic factor with exercise in chronic congestive heart failure patients.
    Cody RJ; Kubo SH; Laragh JH; Atlas SA
    J Appl Physiol (1985); 1992 Oct; 73(4):1637-43. PubMed ID: 1360003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.
    Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H
    Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.